Multiple Sclerosis Clinical Trial
— ODMiMSOfficial title:
Online DBT-Mindfulness Intervention for Symptoms in Multiple Sclerosis: Study Protocol of a Randomized Controlled Trial
NCT number | NCT05938842 |
Other study ID # | ODMiMS229/2022 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | October 2023 |
Est. completion date | July 2024 |
The goal of this clinical trial is to test an Online DBT-Mindfulness intervention in people with Multiple Sclerosis. The results of the online DBT-Mindfulness intervention will be compared to an active control group (psychoeducational intervention) to see if they improve her emotion dysregulation and decentering, and consequently, this benefits also improve symptoms like anxiety, depression, distress, fatigue and quality of life in people with MS.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | July 2024 |
Est. primary completion date | December 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Patients diagnosed MS by a neurologist - to have internet access - to have a Expanded Disability Status Scale (EDSS) score between 0-6'5 - to have adequate Catalan or Spanish language comprehension. Exclusion Criteria: - have a substantial cognitive dèficit - be in concurrent individual or group psychotherapy - have a history of schizophrenia or other psychotic symptoms - have history of alcohol or substance abuse or dependence within 6 months of study entry - have a substantial psychiatric disorder or met DSM 5 criteria for Major Depression or suicide ideation - have meditation experience or are currently practicing meditation or yoga. |
Country | Name | City | State |
---|---|---|---|
Spain | UVic-UCC | Vic | Barcelona |
Lead Sponsor | Collaborator |
---|---|
University of Vic - Central University of Catalonia |
Spain,
Feliu-Soler A, Pascual JC, Borras X, Portella MJ, Martin-Blanco A, Armario A, Alvarez E, Perez V, Soler J. Effects of dialectical behaviour therapy-mindfulness training on emotional reactivity in borderline personality disorder: preliminary results. Clin Psychol Psychother. 2014 Jul-Aug;21(4):363-70. doi: 10.1002/cpp.1837. Epub 2013 Mar 14. — View Citation
Oz HS, Oz F. A psychoeducation program for stress management and psychosocial problems in multiple sclerosis. Niger J Clin Pract. 2020 Nov;23(11):1598-1606. doi: 10.4103/njcp.njcp_462_19. — View Citation
Soler J, Franquesa A, Feliu-Soler A, Cebolla A, Garcia-Campayo J, Tejedor R, Demarzo M, Banos R, Pascual JC, Portella MJ. Assessing decentering: validation, psychometric properties, and clinical usefulness of the Experiences Questionnaire in a Spanish sample. Behav Ther. 2014 Nov;45(6):863-71. doi: 10.1016/j.beth.2014.05.004. Epub 2014 Jun 2. Erratum In: Behav Ther. 2017 Jan;48(1):139-140. — View Citation
Soler J, Valdeperez A, Feliu-Soler A, Pascual JC, Portella MJ, Martin-Blanco A, Alvarez E, Perez V. Effects of the dialectical behavioral therapy-mindfulness module on attention in patients with borderline personality disorder. Behav Res Ther. 2012 Feb;50(2):150-7. doi: 10.1016/j.brat.2011.12.002. Epub 2011 Dec 14. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Feasibility of the study | The feasibility of the programme (DBT-Mindfulness intervention) will be evaluated qualitatively in order to understand perceptions and experiences of the intervention participants. Individual semi-structured interviews will be performed. The interview schedule will consist of a series of broad, open-ended questions, and it will be structurized in three parts, exploring a) feelings and thoughts related to the intervention ; b) the satisfaction with the program and the care received by the professionals; and c) impeding and facilitator factors. Interviews will be performed until saturation of data achieved. | At the end of the intervention (up to 10 weeks) | |
Primary | Changes in emotion dysregulation | Changes in emotion dysregulation will be assessed by the 16-ítem Difficulties in Emotion Regulation Scale (DERS). Higher scores in this scale indicate greater emotion dysregulation (score range 16 to 80). The DERS has good internal consistency and test-retest reliability, and adequate convergent and discriminant validity in large community samples. | baseline (pre-group assignment), at the end of the intervention (up to 10 weeks), and at three-months follow-up | |
Primary | Changes in decentering | Decentering will be measured using The Experiences Questionnaire (EQ), validated in the Spanish population. This instrument is a self - reported questionnaire that examine decentering and rumination. It showed a good reliability and it seems adequate to detect changes after mindfulness-based interventions. | baseline (pre-group assignment), at the end of the intervention (up to 10 weeks) and at three-months follow-up | |
Secondary | Changes in fatigue | The Modified Fatigue Impact Scale (MFIS) will be employed to assess fatigue severity. This questionnaire included 21 items and has been recommended by the Fatigue Guidelines Development Panel of the Multiple Sclerosis Council for Clinical Practice Guidelines. This scale was validated and demonstrated good psychometric properties in Spain. | Baseline (pre-group assignment), at the end of the intervention (up to 10 weeks), and at three-months follow-up | |
Secondary | Changes in depression and anxiety | The Hospital Anxiety and Depression Scale (HADS) is a 14- item measure of anxiety and depression symptoms during the previous week. The total score ranges from 0 to 42, and each subscale (HADS-Anxiety and HADS-Depression) includes 7 items with scores ranging from 0 to 21. Higher scores indicate higher symptom severity. The Spanish version has shown good psychometric properties and high internal consistency. | Baseline (pre-group assignment), at the end of the intervention (up to 10 weeks), and at three-months follow-up | |
Secondary | Changes in stress | The Perceived Stress Scale (PSS-10) consists of 10 items which measure the degree to which a subject appraises situations as stressful during the last month. Scores range from 0 to 40, with higher scores reflecting higher perceived stress. The Spanish version has demonstrated adequate internal consistency, test-retest reliability, validity, and sensitivity to change. | Baseline (pre-group assignment), at the end of the intervention (up to 10 weeks), and at three-months follow-up (up to | |
Secondary | Changes in QoL | QoL will be evaluated by the World Health Organization's WHOQOL-BREF quality of life assessment. The WHOQOL-BREF is a 26-item version of the WHOQOL-100 assessment and examined the individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns. This scale has demonstrated good to excellent psychometric properties of reliability and performs well in preliminary tests of validity. | Baseline (pre-group assignment), at the end of the intervention (up to 10 weeks), and at three-months follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|